CLC bio Delivers Specialized Immunoinformatics Solution to Symphogen A/S
AARHUS, Denmark--(BUSINESS WIRE)--CLC bio has just completed a specialized immunoinformatics solution that is fully customized to fit into Symphogen’s proprietary Symplex™ technology for high throughput identification of antibodies with diversity and specificity customized to a particular therapeutic application.